Durable radiologic and molecular complete response following nivolumab in an HNSCC patient with UV signature and HIV.

MLA

Adibi, Ashkan, et al. “Durable Radiologic and Molecular Complete Response Following Nivolumab in an HNSCC Patient with UV Signature and HIV.” Oral Oncology, vol. 154, July 2024, p. 106859. EBSCOhost, https://doi.org/10.1016/j.oraloncology.2024.106859.

APA

Adibi, A., Tokat, Ü. M., Özgü, E., Mamyrov, N., Aydın, E., Bilgiç, Ş. N., Tutar, O., & Demiray, M. (2024). Durable radiologic and molecular complete response following nivolumab in an HNSCC patient with UV signature and HIV. Oral Oncology, 154, 106859. https://doi.org/10.1016/j.oraloncology.2024.106859

Chicago

Adibi, Ashkan, Ünal Metin Tokat, Eylül Özgü, Nurseit Mamyrov, Esranur Aydın, Şevval Nur Bilgiç, Onur Tutar, and Mutlu Demiray. 2024. “Durable Radiologic and Molecular Complete Response Following Nivolumab in an HNSCC Patient with UV Signature and HIV.” Oral Oncology 154 (July): 106859. doi:10.1016/j.oraloncology.2024.106859.